Background Carpal tunnel syndrome has attracted attention as an occupational disease due to the dramatic increase on its magnitude, and its prevalence in the general population, who's has been reported from a 0.6 to 3.4%. Currently, there are various techniques for its approach. However, there is great controversy when it comes to establishing which of the methods is the most beneficial. The objective of this study was to compare the efficacy of the mini-transverse incision against the traditional longitudinal technique in treatment of carpal tunnel syndrome. Materials and methods A series of cases is presented, prospectively included, of patients with a diagnosis of carpal tunnel syndrome, who are beneficiaries of a government hospital. We present a series of cases with a diagnosis of carpal tunnel syndrome, which were performed with two different techniques. Both techniques were evaluated by comparing the recovery and work reintegration times, as well as the decrease in pain and the absence of complications. Results A total of 8 patients operated with a minimal incision and 9 with a traditional reduced incision were studied. Significant differences were shown in the days taken to return to work, with a median of 17.5 (q25-q75 14–21) days for mini-transverse incision group and of 28 (q25-q75 21–28) days for the longitudinal traditional incision group ( p = 0.002). Likewise, differences were obtained in the visual analogue pain scale during the first week of evaluation 4 vs 7 ( p = 0.000), in contrast to complications where there were no differences at all. Conclusion The results obtained corroborate a greater efficacy of the mini-transverse incision technique, in reducing disability times. This favors the health institution to reduce the costs of rehabilitation and for the patient to have a prompt work reintegration. It is suggested to strengthen the scientific evidence that supports the use of this technique by exploring other areas such as functional status or long-term benefits.
INTRODUCTION: With the increased knowledge about the physiology of liposuction, procedures that involve larger body surface area are now being performed, which means an increased risk of hemorrhage and the need for transfusion. Homologous blood transfusion poses well-known risks, prompting the use of alternative and safer techniques such as autologous donation. To demonstrate the utility of autologousOBJECTIVE: transfusion in a cohort of patients undergoing large volume liposuction. Observational, retrospective andMETHODS: longitudinal cohort study in patients undergoing liposuction, in the period 2017-2021. Autologous donation was performed one month and two weeks prior to surgery, ensuring that all patients were prescribed medication and prophylactic dietary measures to avoid hemoglobin depletion. 40 les of women between 26 and 46 years of age, with a bodyRESULTS AND CONCLUSIONS: mass index between 24 and 30 m/kg2 and a median aspirated volume of 6.3 Lt were analyzed. Quantied bleeding averaged 675 cc. Both initial hemoglobin and hematocrit had statistically signicant differences with values in the postoperative period (pn all. However, vital signs remained stable and no transfusion-associated adverse events occurred. Autologous transfusion is an excellent strategy for the management of bleeding in large volume liposuction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.